Nicotine & Tobacco Research

quit. This involves attempting to reduce harm from an activity without ceasing it completely. One type of harm reduction, which has been advocated, is the use of nicotine replacement therapy (NRT) for smoking reduction (SR). Support for this approach comes from clinical trials and population-based data demonstrat-ing that the use of NRT for SR has the propensity to move smokers toward a quit attempt and that it may, with appropriate behav-ioral support, result in significant reductions in cigarette con-sumption (Beard et al., 2011; Moore, Aveyard, Connock, Wang, & Fry-Smith, 2009). In recent years, a number of regulatory changes have occurred to the NRT framework in several countries, including the United Kingdom, to allow NRT to be licensed for such purposes (Medicines and Healthcare Products Regulatory Agency, 2010). Proposals have also been made to provide NRT for SR as a route to quitting in stop smoking services (SSSs) in the near future (Department of Health, 2010). SSSs were estab-lished in the United Kingdom in 1999 following the publicatio